188 related articles for article (PubMed ID: 16608887)
1. Regression of skeletal manifestations of hyperparathyroidism with oral vitamin D.
Arabi A; Khoury N; Zahed L; Birbari A; El-Hajj Fuleihan G
J Clin Endocrinol Metab; 2006 Jul; 91(7):2480-3. PubMed ID: 16608887
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. [Outcome of osseous lesions of hyperparathyroidism in a patient with chronic renal failure treated with high doses of vitamin D].
Verberckmoes R; Tanghe W; Michielsen P; Vandenbroucke J
J Urol Nephrol (Paris); 1970 Sep; 76(9):790-7. PubMed ID: 5482082
[No Abstract] [Full Text] [Related]
4. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
von Herrath D; Kraft D; Schaefer K; Krempien B
MMW Munch Med Wochenschr; 1974 Sep; 116(37):1573-8. PubMed ID: 4374654
[No Abstract] [Full Text] [Related]
5. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
6. The effects of vitamin D receptor polymorphism on secondary hyperparathyroidism and bone density after renal transplantation.
Giannini S; D'Angelo A; Nobile M; Carraro G; Rigotti P; Silva-Netto F; Pavan S; Marchini F; Zaninotto M; Dalle Carbonare L; Sartori L; Crepaldi G
J Bone Miner Res; 2002 Oct; 17(10):1768-73. PubMed ID: 12369780
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism.
Abdelhadi M; Nordenström J
J Clin Endocrinol Metab; 1998 Nov; 83(11):3845-51. PubMed ID: 9814456
[TBL] [Abstract][Full Text] [Related]
8. Recovery pattern of patients with osteitis fibrosa cystica in primary hyperparathyroidism after successful parathyroidectomy.
Agarwal G; Mishra SK; Kar DK; Singh AK; Arya V; Gupta SK; Mithal A
Surgery; 2002 Dec; 132(6):1075-83; discussion 1083-5. PubMed ID: 12490858
[TBL] [Abstract][Full Text] [Related]
9. Marked direct suppression of primary hyperparathyroidism with osteitis fibrosa cystica by intravenous administration of 1,25-dihydroxycholecalciferol.
Patron P; Gardin JP; Borensztein P; Prigent A; Paillard M
Miner Electrolyte Metab; 1989; 15(6):321-5. PubMed ID: 2615719
[TBL] [Abstract][Full Text] [Related]
10. Current advances in the therapy of secondary hyperparathyroidism and osteitis fibrosa.
Llach F; Nikakhtar B
Miner Electrolyte Metab; 1991; 17(4):250-5. PubMed ID: 1813787
[TBL] [Abstract][Full Text] [Related]
11. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
Barone A; Giusti A; Pioli G; Girasole G; Razzano M; Pizzonia M; Palummeri E; Bianchi G
J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D supplementation after parathyroidectomy: effect on bone mineral density-a randomized double-blind study.
Norenstedt S; Pernow Y; Zedenius J; Nordenström J; Sääf M; Granath F; Nilsson IL
J Bone Miner Res; 2014 Apr; 29(4):960-7. PubMed ID: 24115138
[TBL] [Abstract][Full Text] [Related]
13. Early intervention with intravenous or pulse oral vitamin D therapy is more effective in the treatment of secondary hyperparathyroidism.
Yamada S; Taniguchi M; Tokumoto M; Tsuruya K; Hirakata H; Iida M
Ther Apher Dial; 2010 Aug; 14(4):424-31. PubMed ID: 20649764
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D metabolism during recovery from severe osteitis fibrosa cystica of primary hyperparathyroidism.
Gonzalez-Villapando C; Porath A; Berelowitz M; Marshall L; Favus MJ
J Clin Endocrinol Metab; 1980 Nov; 51(5):1180-3. PubMed ID: 6893459
[TBL] [Abstract][Full Text] [Related]
15. Effect of parathyroidectomy on bone mineral density in hemodialysis patients with secondary hyperparathyroidism: possible usefulness of preoperative determination of parathyroid hormone level for prediction of bone regain.
Yano S; Sugimoto T; Tsukamoto T; Yamaguchi T; Hattori T; Sekita KI; Kaji H; Hattori S; Kobayashi A; Chihara K
Horm Metab Res; 2003 Apr; 35(4):259-64. PubMed ID: 12778370
[TBL] [Abstract][Full Text] [Related]
16. [Vitamin D receptor gene polymorphism and the rate of bone loss of the femur neck and lumbar spine in hemodialized patients with chronic renal failure].
Karkoszka H; Chudek J; Strzelczyk P; Wiecek A; Schmidt-Gayk H; Ritz E; Kokot F
Pol Merkur Lekarski; 1998 Oct; 5(28):199-202. PubMed ID: 10101442
[TBL] [Abstract][Full Text] [Related]
17. Secondary hyperparathyroidism in primary osteoporosis and osteopenia: optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be sufficient for correction.
Yendt ER; Kovacs KA; Jones G
Clin Endocrinol (Oxf); 2008 Dec; 69(6):855-63. PubMed ID: 18419790
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of secondary hyperparathyroidisms of predialysis chronic renal failure with low doses of 1.25(OH)2D3].
Kato N; Kasai K; Kawaguchi Y; Yamamoto H; Shigematu T; Sakai O
Nihon Jinzo Gakkai Shi; 1995 Oct; 37(10):543-8. PubMed ID: 7474506
[TBL] [Abstract][Full Text] [Related]
19. [Bone disease in secondary hyperparathyroidism].
Hayakawa H; Shigematsu T; Kazama JJ
Nihon Rinsho; 2004 Jun; 62 Suppl 6():324-9. PubMed ID: 15250317
[No Abstract] [Full Text] [Related]
20. Glomerular (azotemic) osteodystrophy.
Kyle LH
Annu Rev Med; 1969; 20():259-76. PubMed ID: 4307817
[No Abstract] [Full Text] [Related]
[Next] [New Search]
